Results 11 to 20 of about 57,561 (211)
Pregnancy Complicated by Hereditary Antithrombin Deficiency: A Case Study and Insights From the Literature. [PDF]
Clin Case RepABSTRACT A pregnant woman with hereditary antithrombin deficiency was managed with adjusted‐dose LMWH throughout pregnancy, monitoring D‐dimer and anti‐Xa activity, successfully preventing thrombosis and hemorrhage.
Zhao Y, Yin J, Song J, Zhao Y, Zhang Y.
europepmc +2 more sources
The Influence of Calcium on the Binding of Antithrombin by Antithrombin Inhibitor.
Experimental Biology and Medicine, 1966 Summary and Conclusions1. The reaction between antithrombin and inhibitor has a quantitative requirement for calcium. 2. Calcium is not the inhibitor of antithrombin. 3. Calcium is not required for neutralization of thrombin by antithrombin.
H H, Henstell, M, Kligerman
openaire +2 more sources
Anesthesiology, 2019 Background: There is a lack of consensus on how to manage anticoagulation during veno-venous extracorporeal membrane oxygenation, including antithrombin monitoring and supplementation.
A. Protti +4 more
semanticscholar +1 more source
Haematologica, 2018 Thromboembolism is a serious complication of induction therapy for childhood acute lymphoblastic leukemia. We prospectively compared the efficacy and safety of antithrombotic interventions in the consecutive leukemia trials ALL-BFM 2000 and AIEOP-BFM ALL
J. Greiner +18 more
semanticscholar +1 more source
A test for antithrombin in the blood [PDF]
Experimental Biology and Medicine, 1914 A test is described for the estimation of antithrombin in the blood. The chief advantage of the test is that it is simple, and does not require the preparation of fibrinogen and of thrombin, which are difficult to prepare and to maintain in a pure state.
openaire +2 more sources
Establishment of Reference Intervals for Thrombus Biomarkers in a Single-Center Chinese Population Using Indirect Methods. [PDF]
J Clin Lab AnalThis study established and validated comprehensive RIs for four key thrombus biomarkers (TAT, PIC, TM, and t‐PAIC) in a Chinese population using the Hoffmann and Bhattacharya indirect methods on a large clinical dataset. The tailored RIs offer a practical tool for early detection and risk assessment of thrombotic diseases, supporting more precise and ...
Zhang L, Hu Q, Chen Y, Yuan H.
europepmc +2 more sources
SerpinC1/Antithrombin III in kidney-related diseases
Clinical science, 2017 The gene SerpinC1 encodes a serine protease inhibitor named antithrombin III (ATIII). This protease demonstrates both anticoagulant and anti-inflammatory action.
Zeyuan Lu, Feng Wang, Mingyu Liang
semanticscholar +1 more source
Clinical and applied thrombosis/hemostasis, 2018 Low-dose antithrombin supplementation therapy (1500 IU/d for 3 days) improves outcomes in patients with sepsis-induced disseminated intravascular coagulation (DIC).
M. Hayakawa +3 more
semanticscholar +1 more source
Advanced Materials, EarlyView.A wearable electrochemical microneedle patch integrates Prussian Blue redox transduction with molecularly imprinted polymer recognition for reagent‐free sampling and detection of thrombo‐inflammatory biomarkers in dermal interstitial fluid. The platform tracks thrombin and inflammatory cytokines with sensitive in vitro, ex vivo, and in vivo performance,
Mahmoud Ayman Saleh +11 more
wiley +1 more source
High levels of latent antithrombin in plasma from patients with antithrombin deficiency
Thrombosis and Haemostasis, 2017 Summary Antithrombin is an anticoagulant serpin that efficiently inhibits multiple procoagulant proteases. The cost for the structural flexibility required for this function is the vulnerability to mutations that impact its folding pathway.
M. E. de la Morena-Barrio +14 more
semanticscholar +1 more source